Pay in 4 interest-free payments of $6.80 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Other GLP-1 medications, including Wegovy, Ozempic, Saxenda, Zepbound, Mounjaro, Victoza, Byetta, or Bydureon
The maximum dose for either use is 15 mg once a week
Nausea (most common, typically dose-dependent and transient) Diarrhea or constipation during dose escalation Vomiting, especially when starting or increasing dose Reduced appetite and early satiety Injection site reactions (redness, bruising) Fatigue, particularly in early weeks Rare: Pancreatitis discontinue immediately with severe abdominal pain Rare: Thyroid C-cell effects (contraindicated with MEN2 or thyroid cancer history) Retatrutide (LY3437943) is Eli Lilly's triple GLP-1/GIP/glucagon receptor agonist in Phase III clinical trials
It's a good idea to report persistent changes to your provider
US$ 22.03
US$ 20.38
US$ 25.17
US$ 23.31
US$ 26.69
US$ 24.48
